Aluminum Chloride Hexahydrate; Used To Treat Hyperhidrosis, Excessive Sweating

(MENAFN- Coherent Market Insights) Aluminum chloride hexahydrate is soluble in wide range of solvents, such as ether, chloroform, propylene glycol, ethanol, and water. It has low melting and boiling points, non-flammable, and exhibits good electrical conduction. It is produced by dissolution of aluminum oxide in hydrochloric acid. Aluminum chloride hexahydrate is widely used in the metal processing and pharmaceutical industries. It is used to manufacture aluminum metal, as a catalyst in chemical synthesis. Nowadays, it is being used in water treatment areas as well.

Aluminum chloride hexahydrate is used to treat hyperhidrosis, excessive sweating. It works as an antiperspirant that works by affecting sweat-producing cells. Some studies claim that it may cause breast cancer because it has carcinogenic properties. However, these claims have not been validated due to sufficient evidence. Aluminum chloride hexahydrate is one of the most commonly used chemicals for corrosion resistance. It is also used in the automotive industry for protecting and strengthening the connections of internal combustion engine components such as cylinders and piston bearings.

The main properties of aluminum chlorate hexahydrate that gives it its corrosion resistant properties is due to the intensions of the molecule. When the molecules of this compound are in their liquid state, the hydrogen bonding between them becomes stronger and leads to increased friction and fewer break-up points. When these properties are applied on steel, it helps to reduce corrosion to a great extent. In fact, there have been numerous patents filed on this technology and more are on the way.

Hyperhidrosis is the most common skin condition that severely impacts the quality of life of affected patients. Aluminum chloride hexahydrate is considered first-line treatment for patients with mild-to-moderate hyperhidrosis. Moreover, demand for aluminum chloride hexahydrate is increasing significantly due to the rapidly growing pharmaceutical and consumer goods market. According to the Pharmaceutical Research and Manufacturers of America, U.S. firms conduct over half the world's R&D in pharmaceuticals (US$75 billion) and hold the intellectual property rights on most new medicines.

MENAFN15032021005305011848ID1101751884